Matthew Gillmor
Stock Analyst
(n/a)
# 4,492
Out of 4,496 analysts
19
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Upgrades: Outperform | n/a | $9.09 | - | 8 | Nov 13, 2020 | |
| MDRX Veradigm | Downgrades: Neutral | n/a | $9.90 | - | 3 | Oct 19, 2020 | |
| PHR Phreesia | Maintains: Outperform | n/a | $22.92 | - | 2 | Apr 24, 2020 | |
| MD Pediatrix Medical Group | Maintains: Neutral | n/a | $7.52 | - | 1 | Apr 21, 2020 | |
| HSTM HealthStream | Downgrades: Neutral | n/a | $30.38 | - | 2 | Jun 14, 2018 | |
| EVH Evolent Health | Maintains: Outperform | n/a | $19.69 | - | 2 | Sep 28, 2017 | |
| MMS Maximus | Initiates: Neutral | n/a | $89.98 | - | 1 | Sep 1, 2017 |
Teladoc Health
Nov 13, 2020
Upgrades: Outperform
Price Target: n/a
Current: $9.09
Upside: -
Veradigm
Oct 19, 2020
Downgrades: Neutral
Price Target: n/a
Current: $9.90
Upside: -
Phreesia
Apr 24, 2020
Maintains: Outperform
Price Target: n/a
Current: $22.92
Upside: -
Pediatrix Medical Group
Apr 21, 2020
Maintains: Neutral
Price Target: n/a
Current: $7.52
Upside: -
HealthStream
Jun 14, 2018
Downgrades: Neutral
Price Target: n/a
Current: $30.38
Upside: -
Evolent Health
Sep 28, 2017
Maintains: Outperform
Price Target: n/a
Current: $19.69
Upside: -
Maximus
Sep 1, 2017
Initiates: Neutral
Price Target: n/a
Current: $89.98
Upside: -